These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 30690115)
1. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115 [TBL] [Abstract][Full Text] [Related]
2. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations. Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y; Xie XY; Mei XG Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204 [TBL] [Abstract][Full Text] [Related]
7. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound. Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063 [TBL] [Abstract][Full Text] [Related]
9. Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol. Miele D; Catenacci L; Sorrenti M; Rossi S; Sandri G; Malavasi L; Dacarro G; Ferrari F; Bonferoni MC Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480614 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles. Ahmad N; Ahmad R; Alam MA; Ahmad FJ Chem Cent J; 2018 May; 12(1):65. PubMed ID: 29796830 [TBL] [Abstract][Full Text] [Related]
11. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma. Lee SY; Koo JS; Yang M; Cho HJ J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352 [TBL] [Abstract][Full Text] [Related]
12. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice. Kefayat A; Vaezifar S Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043 [TBL] [Abstract][Full Text] [Related]
14. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia. Ahmad N; Ahmad R; Alam MA; Ahmad FJ Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380 [TBL] [Abstract][Full Text] [Related]
15. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models. Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
18. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873 [TBL] [Abstract][Full Text] [Related]
19. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850 [TBL] [Abstract][Full Text] [Related]
20. Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability. Liu C; Zhang S; McClements DJ; Wang D; Xu Y J Agric Food Chem; 2019 May; 67(18):5113-5121. PubMed ID: 31013074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]